Answers are grounded in this paper and cite their sources.
Observational analysis reveals health-related quality of life predictors in patients with idiopathic pulmonary fibrosis, indicating the significant impact of disease on wellness.
Background and objectives: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive Interstitial lung disease (ILD) that has a significant impact on the health-related quality of life (HRQoL). There are generic and disease-specific questionnaires to assess this, but no literature from India exists. Hence we decided to estimate HRQoL and to determine its predictors in a cohort of patients attending a tertiary care centre in Southern India. Methods: Consecutive consenting patients diagnosed with IPF by the ILD MDD between September 2023 and August 2024 were self-administered the St. George’s Respiratory Questionnaire (SGRQ) and the King’s Brief Interstitial Lung Disease (KBILD) questionnaire to assess the HRQoL. Results: In all, 70 patients with IPF were recruited into the study. The median total SGRQ was 35.9 (23.9–57.8), and the median total KBILD was 54.5 (46.4–65.6). Based on SGRQ (>30), 63% (44/70) and based on KBILD (≤50), 34% (24/70) had a poor quality of life. The SGRQ was significantly lower in those not on antifibrotics across all domains, with a trend towards near significance in the activity domain. The Gender, Age, Physiology (GAP) Index had a significant association with the KBILD – breathlessness and activity domain ( P value = 0.01) and the total score ( P value = 0.02). Conclusion: This is the first Indian study reporting HRQoL in IPF. IPF impacts HRQoL drastically, with a predominant impact on physical wellness and a lesser effect on psychological well-being. KBILD is associated with the GAP index. A larger study is required to identify independent factors associated with HRQoL.
No takes yet. Share an insight, caveat, or question.
Barney et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: